Phase 3 Trial Results Grant New Validity to Controversial Sputnik V Vaccine
On February 2nd, results from a Phase 3 clinical trial showed the Sputnik V vaccine, developed by the Gamaleya Institute in Moscow, was 91.6% effective against COVID-19. The vaccine was …
Read More